Form 8-K - Current report:
SEC Accession No. 0001193125-24-025266
Filing Date
2024-02-06
Accepted
2024-02-06 16:07:04
Documents
16
Period of Report
2024-02-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d736911d8k.htm   iXBRL 8-K 25776
2 EX-3.1 d736911dex31.htm EX-3.1 29660
3 EX-3.2 d736911dex32.htm EX-3.2 128520
  Complete submission text file 0001193125-24-025266.txt   355069

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA anro-20240206.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE anro-20240206_lab.xml EX-101.LAB 18723
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anro-20240206_pre.xml EX-101.PRE 11722
17 EXTRACTED XBRL INSTANCE DOCUMENT d736911d8k_htm.xml XML 3845
Mailing Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022
Business Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 24600265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)